This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stanford, J. L. Articles by Ostrander, E. A. Search for Related Content PubMed PubMed Citation Articles by Stanford, J. L. Articles by Ostrander, E. A.

Polymorphic Repeats in the Androgen Receptor Gene: Molecular Markers of Prostate Cancer Risk¹

Divisions of Public Health Sciences [J. L. S., K. G. W., B. A. B.] and Clinical Research [J. J. J., C. L. N., M. G., E. A. O.], Fred Hutchinson Cancer Research Center, Seattle, Washington 98104

We analyzed the polymorphic (CAG)_n and (GGN)_n regions within the androgen receptor gene from participants in a population-based case-control study of prostate cancer in middle-aged (40–64 years) Caucasian men. The associations between repeat lengths and risk of prostate cancer and the effects of confounding and modifying factors, such as age, family history of prostate cancer, and body mass index, were evaluated. DNA was available for 301 cases and 277 controls. The overall age-adjusted relative odds of prostate cancer associated with the number of (CAG) repeats as a continuous variable was 0.97 [95% confidence interval (CI), 0.92–1.03], suggesting a 3% decrease in risk of prostate cancer for each additional (CAG) repeat. Further analyses identified several subgroups at increased risk. These were men with less than the median number of CAG repeats (<22) that were younger [<60 years; relative odds (RO), 1.47; 95% CI, 0.96–2.25], had an affected first-degree relative (RO, 1.59; 95% CI, 0.62–4.14), or were relatively thin (Quetelet index < 24.4; RO, 2.21; 95% CI, 1.07–4.69). Although only the latter result was statistically significant, these results are provocative and support the hypothesis that (CAG)_n array length is a predictor of risk for prostate cancer. Similar analyses of (GGN)_n showed that with the exception of men with a family history of prostate cancer and those in the highest quartile of body mass index, men with 16 repeats had higher risk estimates than did men with >16 repeats. Overall, those men who had 16 repeats had a significant elevation in risk (RO, 1.60; 95% CI, 1.07–2.41). When both repeat lengths were considered jointly, the subgroup with two short repeats (CAG, <22; GGN, 16) had a 2-fold elevation in odds (RO, 2.05; 95% CI, 1.09–3.84) relative to those with two long repeats (CAG, 22; GGN, >16). These data suggest that determination of both androgen receptor repeats within germ-line DNA may be useful in assessing an individual's risk of developing prostate cancer.

¹ This work was supported in part by National Cancer Institute Grant R01 CA56678 (to J. L. S.) and contract N01-CN-05230, with additional support from the Fred Hutchinson Cancer Research Center; an award from the CaP CURE Foundation (to E. A. O.); and American Cancer Society Junior Faculty Award JFRA-558 (to E. A. O.).

² Current address: Division of Public Health Sciences, University of Utah, 546 Chipeta Way, Suite 2100, Salt Lake City, UT 84108.

³ Current address: Millennium Pharmaceuticals, Inc., 640 Memorial Drive, 5th floor, Cambridge, MA 02139.

⁴ To whom requests for reprints should be addressed, at Clinical Research Division, Fred Hutchinson Cancer Research Center, 1124 Columbia Street M-318, Seattle, WA 98104. Phone: (206) 667-6979; Fax: (206) 667-6124.

Received 10/ 3/96. Accepted 1/15/97.

This article has been cited by other articles:

				J. Li, R. J. Coates, M. Gwinn, and M. J. Khoury Steroid 5-{alpha}-Reductase Type 2 (SRD5a2) Gene Polymorphisms and Risk of Prostate Cancer: A HuGE Review Am. J. Epidemiol., November 13, 2009; (2009) kwp318v1. [Abstract] [Full Text] [PDF]

				V. Bogaert, G. Vanbillemont, Y. Taes, D. De Bacquer, E. Deschepper, K. Van Steen, and J.-M. Kaufman Small effect of the androgen receptor gene GGN repeat polymorphism on serum testosterone levels in healthy men Eur. J. Endocrinol., July 1, 2009; 161(1): 171 - 177. [Abstract] [Full Text] [PDF]

				M. L. Cutress, H. C. Whitaker, I. G. Mills, M. Stewart, and D. E. Neal Structural basis for the nuclear import of the human androgen receptor J. Cell Sci., April 1, 2008; 121(7): 957 - 968. [Abstract] [Full Text] [PDF]

				M. A. Albertelli, O. A. O'Mahony, M. Brogley, J. Tosoian, M. Steinkamp, S. Daignault, K. Wojno, and D. M. Robins Glutamine tract length of human androgen receptors affects hormone-dependent and -independent prostate cancer in mice Hum. Mol. Genet., January 1, 2008; 17(1): 98 - 110. [Abstract] [Full Text] [PDF]

				S. Lindstrom, F. Wiklund, H.-O. Adami, K. A. Balter, J. Adolfsson, and H. Gronberg Germ-Line Genetic Variation in the Key Androgen-Regulating Genes Androgen Receptor, Cytochrome P450, and Steroid-5-{alpha}-Reductase Type 2 Is Important for Prostate Cancer Development. Cancer Res., November 15, 2006; 66(22): 11077 - 11083. [Abstract] [Full Text] [PDF]

				S. Rajender, V. Rajani, N. J. Gupta, B. Chakravarty, L. Singh, and K. Thangaraj No Association of Androgen Receptor GGN Repeat Length Polymorphism With Infertility in Indian Men J Androl, November 1, 2006; 27(6): 785 - 789. [Abstract] [Full Text] [PDF]

				N. Tsuchiya, L. Wang, H. Suzuki, T. Segawa, H. Fukuda, S. Narita, M. Shimbo, T. Kamoto, K. Mitsumori, T. Ichikawa, et al. Impact of IGF-I and CYP19 Gene Polymorphisms on the Survival of Patients With Metastatic Prostate Cancer J. Clin. Oncol., May 1, 2006; 24(13): 1982 - 1989. [Abstract] [Full Text] [PDF]

				A Garolla, A Ferlin, C Vinanzi, A Roverato, G Sotti, W Artibani, and C Foresta Molecular analysis of the androgen receptor gene in testicular cancer Endocr. Relat. Cancer, September 1, 2005; 12(3): 645 - 655. [Abstract] [Full Text] [PDF]

				C Hughes, A Murphy, C Martin, O Sheils, and J O'Leary Molecular pathology of prostate cancer J. Clin. Pathol., July 1, 2005; 58(7): 673 - 684. [Abstract] [Full Text] [PDF]

				E. A. Platz, M. F. Leitzmann, N. Rifai, P. W. Kantoff, Y.-C. Chen, M. J. Stampfer, W. C. Willett, and E. Giovannucci Sex Steroid Hormones and the Androgen Receptor Gene CAG Repeat and Subsequent Risk of Prostate Cancer in the Prostate-Specific Antigen Era Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1262 - 1269. [Abstract] [Full Text] [PDF]

				J. T. E. Lim, M. Mansukhani, and I. B. Weinstein Cyclin-dependent kinase 6 associates with the androgen receptor and enhances its transcriptional activity in prostate cancer cells PNAS, April 5, 2005; 102(14): 5156 - 5161. [Abstract] [Full Text] [PDF]

				A. Ferlin, A. Garolla, A. Bettella, L. Bartoloni, C. Vinanzi, A. Roverato, and C. Foresta Androgen receptor gene CAG and GGC repeat lengths in cryptorchidism Eur. J. Endocrinol., March 1, 2005; 152(3): 419 - 425. [Abstract] [Full Text] [PDF]

				B. K. Dunn, D. L. Wickerham, and L. G. Ford Prevention of Hormone-Related Cancers: Breast Cancer J. Clin. Oncol., January 10, 2005; 23(2): 357 - 367. [Abstract] [Full Text] [PDF]

				M. P. Zeegers, L. A.L.M. Kiemeney, A. M. Nieder, and H. Ostrer How Strong Is the Association Between CAG and GGN Repeat Length Polymorphisms in the Androgen Receptor Gene and Prostate Cancer Risk? Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1765 - 1771. [Abstract] [Full Text] [PDF]

				R. Foley, D. Hollywood, and M. Lawler Molecular pathology of prostate cancer: the key to identifying new biomarkers of disease Endocr. Relat. Cancer, September 1, 2004; 11(3): 477 - 488. [Abstract] [Full Text] [PDF]

				G. Buchanan, M. Yang, A. Cheong, J. M. Harris, R. A. Irvine, P. F. Lambert, N. L. Moore, M. Raynor, P. J. Neufing, G. A. Coetzee, et al. Structural and functional consequences of glutamine tract variation in the androgen receptor Hum. Mol. Genet., August 15, 2004; 13(16): 1677 - 1692. [Abstract] [Full Text] [PDF]

				A. Ferlin, L. Bartoloni, G. Rizzo, A. Roverato, A. Garolla, and C. Foresta Androgen receptor gene CAG and GGC repeat lengths in idiopathic male infertility Mol. Hum. Reprod., June 1, 2004; 10(6): 417 - 421. [Abstract] [Full Text] [PDF]

				D. Milatiner, D. Halle, M. Huerta, E. J. Margalioth, Y. Cohen, A. Ben-Chetrit, M. Gal, T. Mimoni, and T. Eldar-Geva Associations between androgen receptor CAG repeat length and sperm morphology Hum. Reprod., June 1, 2004; 19(6): 1426 - 1430. [Abstract] [Full Text] [PDF]

				Q. Wang, T. S. Udayakumar, T. S. Vasaitis, A. M. Brodie, and J. D. Fondell Mechanistic Relationship between Androgen Receptor Polyglutamine Tract Truncation and Androgen-dependent Transcriptional Hyperactivity in Prostate Cancer Cells J. Biol. Chem., April 23, 2004; 279(17): 17319 - 17328. [Abstract] [Full Text] [PDF]

				C. A. Heinlein and C. Chang Androgen Receptor in Prostate Cancer Endocr. Rev., April 1, 2004; 25(2): 276 - 308. [Abstract] [Full Text] [PDF]

				D. E. BREDESEN, P. MEHLEN, and S. RABIZADEH Apoptosis and Dependence Receptors: A Molecular Basis for Cellular Addiction Physiol Rev, April 1, 2004; 84(2): 411 - 430. [Abstract] [Full Text] [PDF]

				E. O. Lillie, L. Bernstein, S. A. Ingles, W. J. Gauderman, G. E. Rivas, V. Gagalang, T. Krontiris, and G. Ursin Polymorphism in the Androgen Receptor and Mammographic Density in Women Taking and Not Taking Estrogen and Progestin Therapy Cancer Res., February 15, 2004; 64(4): 1237 - 1241. [Abstract] [Full Text] [PDF]

				R. O. Roberts, E. J. Bergstralh, J. M. Cunningham, S. J. Hebbring, S. N. Thibodeau, M. M. Lieber, and S. J. Jacobsen Androgen Receptor Gene Polymorphisms and Increased Risk of Urologic Measures of Benign Prostatic Hyperplasia Am. J. Epidemiol., February 1, 2004; 159(3): 269 - 276. [Abstract] [Full Text] [PDF]

				P. Mehlen and D. E. Bredesen Meeting Report: Cellular Dependence--Old Concept, New Mechanisms Sci. Signal., December 16, 2003; 2003 (213): pe55 - pe55. [Abstract] [Full Text] [PDF]

				A. Liede, W. Zhang, M. L. D. L. Matsuda, A. Tan, and S. A. Narod Androgen Receptor Gene Polymorphism and Breast Cancer Susceptibility in the Philippines Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 848 - 852. [Abstract] [Full Text] [PDF]

				W. G. Nelson, A. M. De Marzo, and W. B. Isaacs Prostate Cancer N. Engl. J. Med., July 24, 2003; 349(4): 366 - 381. [Full Text] [PDF]

				M. Marchesani, A. Hakkarainen, T.-P. Tuomainen, J. Kaikkonen, E. Pukkala, P. Uimari, E. Seppala, M. Matikainen, O.-P. Kallioniemi, J. Schleutker, et al. New Paraoxonase 1 Polymorphism I102V and the Risk of Prostate Cancer in Finnish Men J Natl Cancer Inst, June 4, 2003; 95(11): 812 - 818. [Abstract] [Full Text] [PDF]

				D. J. Lamb, E. Puxeddu, N. Malik, D. L. Stenoien, R. Nigam, G. Y. Saleh, M. Mancini, N. L. Weigel, and M. Marcelli Molecular Analysis of the Androgen Receptor in Ten Prostate Cancer Specimens Obtained Before and After Androgen Ablation J Androl, March 1, 2003; 24(2): 215 - 225. [Abstract] [Full Text] [PDF]

				N. M. Suter, K. E. Malone, J. R. Daling, D. R. Doody, and E. A. Ostrander Androgen Receptor (CAG)n and (GGC)n Polymorphisms and Breast Cancer Risk in a Population-Based Case-Control Study of Young Women Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 127 - 135. [Abstract] [Full Text] [PDF]

				T. R. Rebbeck Inherited Genotype and Prostate Cancer Outcomes Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 945 - 952. [Abstract] [Full Text] [PDF]

				E. Giovannucci Is the Androgen Receptor CAG Repeat Length Significant for Prostate Cancer? : Commentary re: C. Chen et al., Androgen Receptor Polymorphisms and the Incidence of Prostate Cancer. Cancer Epidemiol. Biomark. Prev., 11: 1033-1040, 2002 Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 985 - 986. [Full Text] [PDF]

				C. Chen, N. Lamharzi, N. S. Weiss, R. Etzioni, D. A. Dightman, M. Barnett, D. DiTommaso, and G. Goodman Androgen Receptor Polymorphisms and the Incidence of Prostate Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1033 - 1040. [Abstract] [Full Text] [PDF]

				A. Gsur, M. Preyer, G. Haidinger, T. Zidek, S. Madersbacher, G. Schatzl, M. Marberger, C. Vutuc, and M. Micksche Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk Carcinogenesis, October 1, 2002; 23(10): 1647 - 1651. [Abstract] [Full Text] [PDF]

				G. G. Giles, G. Severi, R. Sinclair, D. R. English, M. R. E. McCredie, W. Johnson, P. Boyle, and J. L. Hopper Androgenetic Alopecia and Prostate Cancer: Findings from an Australian Case-Control Study Cancer Epidemiol. Biomarkers Prev., June 1, 2002; 11(6): 549 - 553. [Abstract] [Full Text] [PDF]

				Y. L. Giwercman, A. Nordenskjold, E. M. Ritzen, K. O. Nilsson, S.-A. Ivarsson, U. Grandell, and A. Wedell An Androgen Receptor Gene Mutation (E653K) in a Family with Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency as well as in Partial Androgen Insensitivity J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2623 - 2628. [Abstract] [Full Text] [PDF]

				K. A. Nelson and J. S. Witte Androgen Receptor CAG Repeats and Prostate Cancer Am. J. Epidemiol., May 15, 2002; 155(10): 883 - 890. [Abstract] [Full Text] [PDF]

				A. W. Hsing, A. P. Chokkalingam, Y.-T. Gao, G. Wu, X. Wang, J. Deng, J. Cheng, I. A. Sesterhenn, F. K. Mostofi, T. Chiang, et al. Polymorphic CAG/CAA Repeat Length in the AIB1/SRC-3 Gene and Prostate Cancer Risk: A Population-based Case-Control Study Cancer Epidemiol. Biomarkers Prev., April 1, 2002; 11(4): 337 - 341. [Abstract] [Full Text] [PDF]

				H. Sasaki, R. A. Betensky, J. G. Cairncross, and D. N. Louis DMBT1 Polymorphisms: Relationship to Malignant Glioma Tumorigenesis Cancer Res., March 1, 2002; 62(6): 1790 - 1796. [Abstract] [Full Text] [PDF]

				A. M. Matsumoto Andropause: Clinical Implications of the Decline in Serum Testosterone Levels With Aging in Men J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2002; 57(2): M76 - 99. [Full Text]

				C. A. Haiman, M. Brown, S. E. Hankinson, D. Spiegelman, G. A. Colditz, W. C. Willett, P. W. Kantoff, and D. J. Hunter The Androgen Receptor CAG Repeat Polymorphism and Risk of Breast Cancer in the Nurses' Health Study Cancer Res., February 1, 2002; 62(4): 1045 - 1049. [Abstract] [Full Text] [PDF]

				A. Mifsud, A. T. Choon, D. Fang, and E.L. Yong Prostate-specific antigen, testosterone, sex-hormone binding globulin and androgen receptor CAG repeat polymorphisms in subfertile and normal men Mol. Hum. Reprod., November 1, 2001; 7(11): 1007 - 1013. [Abstract] [Full Text] [PDF]

				F. Modugno, J. L. Weissfeld, D. L. Trump, J. M. Zmuda, P. Shea, J. A. Cauley, and R. E. Ferrell Allelic Variants of Aromatase and the Androgen and Estrogen Receptors: Toward a Multigenic Model of Prostate Cancer Risk Clin. Cancer Res., October 1, 2001; 7(10): 3092 - 3096. [Abstract] [Full Text] [PDF]

				M. Stanbrough, I. Leav, P. W. L. Kwan, G. J. Bubley, and S. P. Balk Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium PNAS, September 4, 2001; (2001) 191235898. [Abstract] [Full Text] [PDF]

				E. L. Goode, J. L. Stanford, M. A. Peters, M. Janer, M. Gibbs, S. Kolb, M. D. Badzioch, L. Hood, E. A. Ostrander, and G. P. Jarvik Clinical Characteristics of Prostate Cancer in an Analysis of Linkage to Four Putative Susceptibility Loci Clin. Cancer Res., September 1, 2001; 7(9): 2739 - 2749. [Abstract] [Full Text] [PDF]

				M. E. Taplin and S.-M. Ho The Endocrinology of Prostate Cancer J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3467 - 3477. [Full Text] [PDF]

				Y. Giguere, E. Dewailly, J. Brisson, P. Ayotte, N. Laflamme, A. Demers, V.-I. Forest, S. Dodin, J. Robert, and F. Rousseau Short Polyglutamine Tracts in the Androgen Receptor Are Protective against Breast Cancer in the General Population Cancer Res., August 1, 2001; 61(15): 5869 - 5874. [Abstract] [Full Text] [PDF]

				H. N. Lim, R. M. Nixon, H. Chen, I. A. Hughes, and J. R. Hawkins Evidence That Longer Androgen Receptor Polyglutamine Repeats Are a Causal Factor for Genital Abnormalities J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3207 - 3210. [Abstract] [Full Text] [PDF]

				W.-M. Xue, G. A. Coetzee, R. K. Ross, R. Irvine, L. Kolonel, B. E. Henderson, and S. A. Ingles Genetic Determinants of Serum Prostate-specific Antigen levels in Healthy Men from a Multiethnic Cohort Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 575 - 579. [Abstract] [Full Text] [PDF]

				L. Westberg, F. Baghaei, R. Rosmond, M. Hellstrand, M. Landen, M. Jansson, G. Holm, P. Bjorntorp, and E. Eriksson Polymorphisms of the Androgen Receptor Gene and the Estrogen Receptor {beta} Gene Are Associated with Androgen Levels in Women J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2562 - 2568. [Abstract] [Full Text] [PDF]

				G. Buchanan, N. M. Greenberg, H. I. Scher, J. M. Harris, V. R. Marshall, and W. D. Tilley Collocation of Androgen Receptor Gene Mutations in Prostate Cancer Clin. Cancer Res., May 1, 2001; 7(5): 1273 - 1281. [Abstract] [Full Text]

				B. Lin, J. T. White, C. Ferguson, S. Wang, R. Vessella, R. Bumgarner, L. D. True, L. Hood, and P. S. Nelson Prostate Short-Chain Dehydrogenase Reductase 1 (PSDR1): A New Member of the Short-Chain Steroid Dehydrogenase/Reductase Family Highly Expressed in Normal and Neoplastic Prostate Epithelium Cancer Res., February 1, 2001; 61(4): 1611 - 1618. [Abstract] [Full Text]

				E. A. Platz, E. B. Rimm, W. C. Willett, P. W. Kantoff, and E. Giovannucci Racial Variation in Prostate Cancer Incidence and in Hormonal System Markers Among Male Health Professionals J Natl Cancer Inst, December 20, 2000; 92(24): 2009 - 2017. [Abstract] [Full Text] [PDF]

				N. Mononen, K. Syrjäkoski, M. Matikainen, T. L. J. Tammela, J. Schleutker, O.-P. Kallioniemi, J. Trapman, and P. A. Koivisto Two Percent of Finnish Prostate Cancer Patients Have a Germ-line Mutation in the Hormone-binding Domain of the Androgen Receptor Gene Cancer Res., November 1, 2000; 60(22): 6479 - 6481. [Abstract] [Full Text]

				A. Mifsud, S. Ramirez, and E. L. Yong Androgen Receptor Gene CAG Trinucleotide Repeats in Anovulatory Infertility and Polycystic Ovaries J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3484 - 3488. [Abstract] [Full Text]

				A. W. Hsing, Y.-T. Gao, G. Wu, X. Wang, J. Deng, Y.-L. Chen, I. A. Sesterhenn, F. K. Mostofi, J. Benichou, and C. Chang Polymorphic CAG and GGN Repeat Lengths in the Androgen Receptor Gene and Prostate Cancer Risk: A Population-based Case-Control Study in China Cancer Res., September 1, 2000; 60(18): 5111 - 5116. [Abstract] [Full Text]

				M. C. Bosland Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 39 - 66. [Abstract] [Full Text] [PDF]

				K. Mori, T. Ushiyama, K. Inoue, and S. Hukuda Polymorphic CAG repeats of the androgen receptor gene in Japanese male patients with ankylosing spondylitis Rheumatology, May 1, 2000; 39(5): 530 - 532. [Abstract] [Full Text] [PDF]

				E. M. Lange, H. Chen, K. Brierley, H. Livermore, K. J. Wojno, C. D. Langefeld, K. Lange, and K. A. Cooney The Polymorphic Exon 1 Androgen Receptor CAG Repeat in Men with a Potential Inherited Predisposition to Prostate Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2000; 9(4): 439 - 442. [Abstract] [Full Text]

				H.N. Lim, H. Chen, S. McBride, A.M. Dunning, R.M. Nixon, I.A. Hughes, and J.R. Hawkins Longer polyglutamine tracts in the androgen receptor are associated with moderate to severe undermasculinized genitalia in XY males Hum. Mol. Genet., March 22, 2000; 9(5): 829 - 834. [Abstract] [Full Text] [PDF]

				B. E. Henderson and H. S. Feigelson Hormonal carcinogenesis Carcinogenesis, March 1, 2000; 21(3): 427 - 433. [Abstract] [Full Text] [PDF]

				R S Houlston and I P M Tomlinson Detecting low penetrance genes in cancer: the way ahead J. Med. Genet., March 1, 2000; 37(3): 161 - 167. [Abstract] [Full Text]

				W. Xue, R. A. Irvine, M. C. Yu, R. K. Ross, G. A. Coetzee, and S. A. Ingles Susceptibility to Prostate Cancer: Interaction between Genotypes at the Androgen Receptor and Prostate-specific Antigen Loci Cancer Res., February 1, 2000; 60(4): 839 - 841. [Abstract] [Full Text]

				I E YOUNG, K M KURIAN, M A F MACKENZIE, I H KUNKLER, B B COHEN, M L HOOPER, A H WYLLIE, and C M STEEL The CAG repeat within the androgen receptor gene in male breast cancer patients J. Med. Genet., February 1, 2000; 37(2): 139 - 140. [Full Text]

				R. A. Irvine, H. Ma, M. C. Yu, R. K. Ross, M. R. Stallcup, and G. A. Coetzee Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length Hum. Mol. Genet., January 22, 2000; 9(2): 267 - 274. [Abstract] [Full Text] [PDF]

				T. Yasui Correspondence re: J. L. Stanford et al., Polymorphic Receptor in the Androgen Receptor Gene: Molecular Markers of Prostate Cancer Risk. Cancer Res., 57: 1194-1198, 1997. Cancer Res., January 1, 2000; 60(2): 499 - 499. [Full Text]

				A. M. Dunning, S. McBride, J. Gregory, F. Durocher, N. A. Foster, C. S. Healey, N. Smith, P. D. P. Pharoah, R. N. Luben, D. F. Easton, et al. No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer Carcinogenesis, November 1, 1999; 20(11): 2131 - 2135. [Abstract] [Full Text] [PDF]

				R. M. Lunn, D. A. Bell, J. L. Mohler, and J. A. Taylor Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2) Carcinogenesis, September 1, 1999; 20(9): 1727 - 1731. [Abstract] [Full Text] [PDF]

				T. Kawasaki, T. Ushiyama, H. Ueyama, K. Inoue, K. Mori, I. Ohkubo, and S. Hukuda Polymorphic CAG repeats of the androgen receptor gene and rheumatoid arthritis Ann Rheum Dis, August 1, 1999; 58(8): 500 - 502. [Abstract] [Full Text]

				P.-W. Hsiao, D.-L. Lin, R. Nakao, and C. Chang The Linkage of Kennedy's Neuron Disease to ARA24, the First Identified Androgen Receptor Polyglutamine Region-associated Coactivator J. Biol. Chem., July 16, 1999; 274(29): 20229 - 20234. [Abstract] [Full Text] [PDF]

				A. B. Spurdle, G. S. Dite, X. Chen, C. J. Mayne, M. C. Southey, L. E. Batten, H. Chy, L. Trute, M. R. E. McCredie, G. G. Giles, et al. Androgen Receptor Exon 1 CAG Repeat Length and Breast Cancer in Women Before Age Forty Years J Natl Cancer Inst, June 2, 1999; 91(11): 961 - 966. [Abstract] [Full Text] [PDF]

				Y.-S. Zhu, L.-Q. Cai, J. J. Cordero, W. J. Canovatchel, M. D. Katz, and J. Imperato-McGinley A Novel Mutation in the CAG Triplet Region of Exon 1 of Androgen Receptor Gene Causes Complete Androgen Insensitivity Syndrome in a Large Kindred J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1590 - 1594. [Abstract] [Full Text]

				L. N. Kolonel, A. M. Y. Nomura, and R. V. Cooney Dietary Fat and Prostate Cancer: Current Status J Natl Cancer Inst, March 3, 1999; 91(5): 414 - 428. [Abstract] [Full Text] [PDF]

				E. Ruijter, C. van de Kaa, G. Miller, D. Ruiter, F. Debruyne, and J. Schalken Molecular Genetics and Epidemiology of Prostate Carcinoma Endocr. Rev., February 1, 1999; 20(1): 22 - 45. [Abstract] [Full Text]

				M. W. Neff, K. W. Broman, C. S. Mellersh, K. Ray, G. M. Acland, G. D. Aguirre, J. S. Ziegle, E. A. Ostrander, and J. Rine A Second-Generation Genetic Linkage Map of the Domestic Dog, Canis familiaris Genetics, February 1, 1999; 151(2): 803 - 820. [Abstract] [Full Text]

				J. R. Cerhan, A. S. Parker, S. D. Putnam, B. C-H. Chiu, C. F. Lynch, M. B. Cohen, J. C. Torner, and K. P. Cantor Family History and Prostate Cancer Risk in a Population-Based Cohort of Iowa Men Cancer Epidemiol. Biomarkers Prev., January 1, 1999; 8(1): 53 - 60. [Abstract] [Full Text]

				S. Komori, H. Kasumi, R.-i. Kanazawa, K. Sakata, Y. Nakata, H. Kato, and K. Koyama CAG repeat length in the androgen receptor gene of infertile Japanese males with oligozoospermia Mol. Hum. Reprod., January 1, 1999; 5(1): 14 - 16. [Abstract] [Full Text] [PDF]

				C. Lopez-Otin and E. P. Diamandis Breast and Prostate Cancer: An Analysis of Common Epidemiological, Genetic, and Biochemical Features Endocr. Rev., August 1, 1998; 19(4): 365 - 396. [Abstract] [Full Text] [PDF]

				M. Stanbrough, I. Leav, P. W. L. Kwan, G. J. Bubley, and S. P. Balk Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium PNAS, September 11, 2001; 98(19): 10823 - 10828. [Abstract] [Full Text] [PDF]